Market Overview

Intellia Therapeutics, Inc. (NTLA)

63.72 +0.15 (0.24%)

Analyst Ratings

DateResearch FirmActionCurrentPT
2/10/21Chardan CapitalMaintainsBuy85.0
1/08/21Raymond JamesMaintainsOutperform106.0
12/22/20BairdDowngradesNeutral
10/27/20Truist SecuritiesInitiates Coverage OnBuy40.0
10/14/20Wells FargoInitiates Coverage OnOverweight
9/18/20Goldman SachsInitiates Coverage OnBuy33.0
6/02/20Credit SuisseMaintainsNeutral21.0
2/28/20OppenheimerUpgradesOutperform
2/14/20WedbushDowngradesNeutral16.0
11/01/19Raymond JamesUpgradesOutperform24.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter